109 related articles for article (PubMed ID: 8434804)
21. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial.
Marini C; Di Ricco G; Rossi G; Rindi M; Palla R; Giuntini C
Respiration; 1988; 54(3):162-73. PubMed ID: 3073463
[TBL] [Abstract][Full Text] [Related]
22. [Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
Cassin M; Charmet PA; Rellini G; Molaro G; Bitto S; Brieda M; Zanuttini D
G Ital Cardiol; 1987 Jul; 17(7):601-4. PubMed ID: 3678711
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
Hursting MJ; Verme-Gibboney CN
J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
[TBL] [Abstract][Full Text] [Related]
24. [Value of moderate doses of urokinase combined with heparin in the treatment of massive pulmonary embolism. A retrospective study of 33 cases].
Laaban JP; Poubeau P; Horellou MH; Ecoiffier J; Conard J; Samama M; Rochemaure J
Ann Med Interne (Paris); 1989; 140(7):551-6. PubMed ID: 2692486
[TBL] [Abstract][Full Text] [Related]
25. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.
Ouriel K; Veith FJ; Sasahara AA
N Engl J Med; 1998 Apr; 338(16):1105-11. PubMed ID: 9545358
[TBL] [Abstract][Full Text] [Related]
26. Local thrombolysis in patients with dural venous thrombosis unresponsive to heparin.
Sujith OK; Krishnan R; Asraf V; Rahman A; Girija AS
J Stroke Cerebrovasc Dis; 2008; 17(2):95-100. PubMed ID: 18346652
[TBL] [Abstract][Full Text] [Related]
27. Thrombolysis to treat arterial thrombotic complications of heparin-induced thrombocytopenia.
Calligaro KD; Kansagra A; Dougherty MJ; Savarese RP; DeLaurentis DA
Ann Vasc Surg; 1995 Jul; 9(4):397-400. PubMed ID: 8527343
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis].
Delagardelle C; Harf C; Dondelinger RF; Goffette P; Beissel J; Pesch C; Welter R
Arch Mal Coeur Vaiss; 1990 Jan; 83(1):113-5. PubMed ID: 2106299
[TBL] [Abstract][Full Text] [Related]
29. [Clinical use of thrombolytic agents].
Laprevote-Heully MC; Lambert H; Larcan A
Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
[No Abstract] [Full Text] [Related]
30. Thrombolytic therapy for arterial occlusion: a mixed blessing.
Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE
Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090
[TBL] [Abstract][Full Text] [Related]
31. Blood coagulation changes during effective thrombolysis using urokinase and heparin.
Schöffel G; Zimmermann R; Harenberg J; Mörl H
Thromb Res; 1982 Jan 1-15; 25(1-2):11-21. PubMed ID: 6175040
[TBL] [Abstract][Full Text] [Related]
32. Reducing the use of coagulation test panels.
Amukele TK; Baird GS; Chandler WL
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):688-95. PubMed ID: 21934488
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy and safety of the thrombolytic therapy with urokinase after systemic-pulmonary shunt].
Zhang BH; Tang W; Yang G; Zhao YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):624-7. PubMed ID: 19968085
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of Rt-pa thrombolysis combined with PGE1 in patients with peripheral arterial occlusions.
Kröger K; Buss C; Rudofsky G
Angiology; 2000 May; 51(5):377-84. PubMed ID: 10826854
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment with heparin in thrombolytic therapy with Urokinase. Heparin-urokinase therapy.
Bizzi B; Leone G; Accorrà F
Haemostasis; 1976; 5(3):147-54. PubMed ID: 1002001
[TBL] [Abstract][Full Text] [Related]
36. [Nephrotic syndrome complicated with intracranial venous thrombosis treated with urokinase: report of 5 cases].
Xia ZK; He X; Fan ZM; Liu GL; Gao YF; Fu J; Ren XG; Mao S; Huang Q
Zhonghua Er Ke Za Zhi; 2010 May; 48(5):338-41. PubMed ID: 20654032
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
38. Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis.
van de Loo JC; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Asbeck F; Marbet GA; Schmitt HE; Sewell AF; Duckert F
Thromb Haemost; 1983 Oct; 50(3):660-3. PubMed ID: 6359570
[TBL] [Abstract][Full Text] [Related]
39. Urokinase-mediated thrombolysis: a dose-response relationship in cats. Work in progress.
Hedlund LJ; Carlson JE; Urness M; Bildsoe MC; Yedlicka JW; Castaneda-Zuniga WR; Amplatz K; Hunter DW
J Vasc Interv Radiol; 1991 Aug; 2(3):349-52. PubMed ID: 1799780
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
Raabe RD
J Vasc Interv Radiol; 2010 Aug; 21(8):1165-72. PubMed ID: 20656221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
